Bortezomib plus dexamethasone induction improves outcome of patients with t(4;14) myeloma but not outcome of patients with del(17p).
暂无分享，去创建一个
P. Moreau | S. Minvielle | H. Avet-Loiseau | M. Macro | X. Leleu | G. Marit | C. Mathiot | T. Facon | J. Harousseau | M. Attal | L. Campion | M. Roussel | A. Stoppa | M. Wetterwald | C. Hulin | D. Caillot | L. Benboubker | C. Guérin-Charbonnel | L. Voillat | B. Kolb